Global hepatitis C elimination: an investment framework

Alisa Pedrana; Jessica Howell; Nick Scott; Sophia Schroeder; Christian Kuschel; Jeffrey V. Lazarus; Rifat Atun; Ricardo Baptista-Leite; Ellen 't Hoen; Sharon J. Hutchinson; Lisa Aufegger; Raquel Peck; Annette H. Sohn; Tracy Swan; Mark Thursz; Olufunmilayo Lesi; Manik Sharma; John Thwaites; David P. Wilson; Margaret Hellard

doi:10.1016/s2468-1253(20)30010-8

Global hepatitis C elimination: an investment framework

Alisa Pedrana^*
, Jessica Howell
, Nick Scott
, Sophia Schroeder
, Christian Kuschel
, Jeffrey V. Lazarus
, Rifat Atun
, Ricardo Baptista-Leite
, Ellen 't Hoen
, Sharon J. Hutchinson
, Lisa Aufegger
, Raquel Peck
, Annette H. Sohn
, Tracy Swan
, Mark Thursz
, Olufunmilayo Lesi
, Manik Sharma
, John Thwaites
, David P. Wilson
, Margaret Hellard

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

39 Citations (Scopus)

Abstract

WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.

Original language	English
Pages (from-to)	927-939
Number of pages	13
Journal	The lancet. Gastroenterology & hepatology
Volume	5
Issue number	10
DOIs	https://doi.org/10.1016/s2468-1253(20)30010-8
Publication status	Published - Oct 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/s2468-1253(20)30010-8

Cite this

Pedrana, A., Howell, J., Scott, N., Schroeder, S., Kuschel, C., Lazarus, J. V., Atun, R., Baptista-Leite, R., 't Hoen, E., Hutchinson, S. J., Aufegger, L., Peck, R., Sohn, A. H., Swan, T., Thursz, M., Lesi, O., Sharma, M., Thwaites, J., Wilson, D. P., & Hellard, M. (2020). Global hepatitis C elimination: an investment framework. The lancet. Gastroenterology & hepatology, 5(10), 927-939. https://doi.org/10.1016/s2468-1253(20)30010-8

@article{2e194ee1e3564540983761b3996c0ad5,

title = "Global hepatitis C elimination: an investment framework",

abstract = "WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.",

author = "Alisa Pedrana and Jessica Howell and Nick Scott and Sophia Schroeder and Christian Kuschel and Lazarus, \{Jeffrey V.\} and Rifat Atun and Ricardo Baptista-Leite and \{'t Hoen\}, Ellen and Hutchinson, \{Sharon J.\} and Lisa Aufegger and Raquel Peck and Sohn, \{Annette H.\} and Tracy Swan and Mark Thursz and Olufunmilayo Lesi and Manik Sharma and John Thwaites and Wilson, \{David P.\} and Margaret Hellard",

note = "Publisher Copyright: {\textcopyright} 2020 Elsevier Ltd",

year = "2020",

month = oct,

doi = "10.1016/s2468-1253(20)30010-8",

language = "English",

volume = "5",

pages = "927--939",

journal = "The lancet. Gastroenterology \& hepatology",

issn = "2468-1253",

publisher = "Elsevier Ltd.",

number = "10",

}

Pedrana, A, Howell, J, Scott, N, Schroeder, S, Kuschel, C, Lazarus, JV, Atun, R, Baptista-Leite, R, 't Hoen, E, Hutchinson, SJ, Aufegger, L, Peck, R, Sohn, AH, Swan, T, Thursz, M, Lesi, O, Sharma, M, Thwaites, J, Wilson, DP & Hellard, M 2020, 'Global hepatitis C elimination: an investment framework', The lancet. Gastroenterology & hepatology, vol. 5, no. 10, pp. 927-939. https://doi.org/10.1016/s2468-1253(20)30010-8

TY - JOUR

T1 - Global hepatitis C elimination

T2 - an investment framework

AU - Pedrana, Alisa

AU - Howell, Jessica

AU - Scott, Nick

AU - Schroeder, Sophia

AU - Kuschel, Christian

AU - Lazarus, Jeffrey V.

AU - Atun, Rifat

AU - Baptista-Leite, Ricardo

AU - 't Hoen, Ellen

AU - Hutchinson, Sharon J.

AU - Aufegger, Lisa

AU - Peck, Raquel

AU - Sohn, Annette H.

AU - Swan, Tracy

AU - Thursz, Mark

AU - Lesi, Olufunmilayo

AU - Sharma, Manik

AU - Thwaites, John

AU - Wilson, David P.

AU - Hellard, Margaret

PY - 2020/10

Y1 - 2020/10

N2 - WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.

AB - WHO has set global targets for the elimination of hepatitis B and hepatitis C as a public health threat by 2030. However, investment in elimination programmes remains low. To help drive political commitment and catalyse domestic and international financing, we have developed a global investment framework for the elimination of hepatitis B and hepatitis C. The global investment framework presented in this Health Policy paper outlines national and international activities that will enable reductions in hepatitis C incidence and mortality, and identifies potential sources of funding and tools to help countries build the economic case for investing in national elimination activities. The goal of this framework is to provide a way for countries, particularly those with minimal resources, to gain the substantial economic benefit and cost savings that come from investing in hepatitis C elimination.

UR - https://www.scopus.com/pages/publications/85089362398

U2 - 10.1016/s2468-1253(20)30010-8

DO - 10.1016/s2468-1253(20)30010-8

M3 - Review article

C2 - 32730786

AN - SCOPUS:85089362398

SN - 2468-1253

VL - 5

SP - 927

EP - 939

JO - The lancet. Gastroenterology & hepatology

JF - The lancet. Gastroenterology & hepatology

IS - 10

ER -

Global hepatitis C elimination: an investment framework

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

CIIS: Center for Interdisciplinary Research in Health

Cite this

Global hepatitis C elimination: an investment framework

Abstract

UN SDGs

Access to Document

Other files and links

Fingerprint

Projects

CIIS: Center for Interdisciplinary Research in Health

Cite this